Bio Protocol vs Irys — how do they compare? Bio Protocol trades at Rp427.21 (market cap Rp972,61M, Rp151,33M 24h volume), while Irys trades at Rp300.21 (market cap Rp776,25M, Rp114,44M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Irys's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Irys for 2 Days on average.
| BIO | IRYS | |
|---|---|---|
Market Cap | Rp972,61M | Rp776,25M |
Volume (24h) | Rp151,33M | Rp114,44M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 2,6B IRYS |
Typical Hold Time | 18 Days | 2 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Irys is currently trading at Rp308.364 with a market cap of Rp794.82 million, showing bullish technical signals with moving averages strongly favoring buyers (9-4-0). The token is consolidating near resistance at R1 (Rp303) with neutral oscillators suggesting potential for breakout. Average hold time of 2 days indicates short-term trading activity. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautiously optimistic with technical momentum supporting upward potential, though limited fundamental developments and low market cap present both opportunity for growth and significant volatility risks. Key opportunities include breakout above resistance levels, while major risks involve low liquidity and absence of recent ecosystem updates.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →IRYS is the native token of Irys, a Layer 1 programmable data chain that combines on-chain data storage and smart contract execution. Its IrysVM allows smart contracts to access and interact directly with stored data, supporting applications such as AI and DeFi. IRYS is used to pay for data storage and computation, secure the network through staking, and reward network participants.
Read more on IRYS →